Vita Life Sciences Limited (ASX:VLS)

Market Cap	96.88M
Revenue (ttm)	79.51M
Net Income (ttm)	8.78M
Shares Out	55.36M
EPS (ttm)	0.16
PE Ratio	11.08
Forward PE	n/a
Dividend	0.10 (5.71%)
Ex-Dividend Date	Mar 21, 2025

Volume	545
Average Volume	54,171
Open	1.800
Previous Close	1.750
Day's Range	1.800 - 1.815
52-Week Range	1.620 - 2.400
Beta	0.48
RSI	40.45
Earnings Date	May 26, 2025

About Vita Life Sciences

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. The company was founded in 1947 and is headquartered in Kirrawee, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 350
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VLS

Financial Performance

In 2024, Vita Life Sciences's revenue was 79.51 million, an increase of 8.28% compared to the previous year's 73.43 million. Earnings were 8.78 million, a decrease of -3.26%.